Yow‐Ming Wang

c-Jun N-Terminal Kinases Mediate Reactivation of Akt and Cardiomyocyte Survival After Hypoxic Injury In Vitro and In Vivo

Zhili Shao, Kausik Bhattacharya, Eileen Hsich et al. · Circulation Research · 2005 · 122 citations

Phase I and Pharmacokinetic Study of the Novel MDR1 and MRP1 Inhibitor Biricodar Administered Alone and in Combination With Doxorubicin

Ronald A. Peck, Jan Hewett, Matthew W. Harding et al. · Journal of Clinical Oncology · 2001 · 106 citations

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)

Steven P. Piccoli, Devangi Mehta, Alessandra Vitaliti et al. · Bioanalysis · 2019 · 92 citations · Full text

Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors

Peiming Ma, Bingbing Yang, Yow‐Ming Wang et al. · The Journal of Clinical Pharmacology · 2009 · 84 citations

Oncology, Pharmacokinetic Modeling, Medicine +13

The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor

John P. Duffy, Edmund Harrington, Francesco G. Salituro et al. · ACS Medicinal Chemistry Letters · 2011 · 82 citations · Full text